These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15793355)

  • 1. Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection.
    Cho JH; Chung WS; Song KJ; Na BK; Kang SW; Song CY; Kim TS
    Korean J Parasitol; 2005 Mar; 43(1):19-25. PubMed ID: 15793355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
    Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
    Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis.
    Xu J; Hiramatsu R; Suhaimi H; Kato T; Fujimoto A; Tokiwa T; Ike K; Park EY
    Vaccine; 2019 Oct; 37(43):6426-6434. PubMed ID: 31515150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
    Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant Neospora caninum antigens purified from silkworm larvae for the protection of N. caninum infection in mice.
    Yoshimoto M; Otsuki T; Itagaki K; Kato T; Kohsaka T; Matsumoto Y; Ike K; Park EY
    J Biosci Bioeng; 2015 Dec; 120(6):715-9. PubMed ID: 25935502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.
    Monney T; Rütti D; Schorer M; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2011 Sep; 29(40):6967-75. PubMed ID: 21787824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene.
    Nishikawa Y; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
    Vaccine; 2001 Feb; 19(13-14):1710-6. PubMed ID: 11166895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
    Srinivasan S; Mueller J; Suana A; Hemphill A
    J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.
    Haldorson GJ; Mathison BA; Wenberg K; Conrad PA; Dubey JP; Trees AJ; Yamane I; Baszler TV
    Int J Parasitol; 2005 Nov; 35(13):1407-15. PubMed ID: 16051244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection.
    Nishikawa Y; Inoue N; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
    Vaccine; 2001 Jan; 19(11-12):1381-90. PubMed ID: 11163660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
    Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
    Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus.
    Nishikawa Y; Kousaka Y; Fukumoto S; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
    Parasitol Res; 2000 Nov; 86(11):934-9. PubMed ID: 11097303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
    Alaeddine F; Keller N; Leepin A; Hemphill A
    J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
    Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
    J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
    Tuo W; Zhao Y; Zhu D; Jenkins MC
    Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle.
    Nishimura M; Kohara J; Kuroda Y; Hiasa J; Tanaka S; Muroi Y; Kojima N; Furuoka H; Nishikawa Y
    Vaccine; 2013 Aug; 31(35):3528-35. PubMed ID: 23742998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Neospora caninum surface protein NcSRS2 based on baculovirus expression system and its application for serodiagnosis of Neospora infection.
    Nishikawa Y; Kousaka Y; Tragoolpua K; Xuan X; Makala L; Fujisaki K; Mikami T; Nagasawa H
    J Clin Microbiol; 2001 Nov; 39(11):3987-91. PubMed ID: 11682519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine immune response to inoculation with Neospora caninum surface antigen SRS2 lipopeptides mimics immune response to infection with live parasites.
    Baszler TV; Shkap V; Mwangi W; Davies CJ; Mathison BA; Mazuz M; Resnikov D; Fish L; Leibovitch B; Staska LM; Savitsky I
    Clin Vaccine Immunol; 2008 Apr; 15(4):659-67. PubMed ID: 18305105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.